awmsg logo



ceftazidime/avibactam (Zavicefta®)


Reference No. 2181

Publication date:
30/09/2016


Appraisal information

ceftazidime/avibactam (Zavicefta®) powder for concentrate for solution for infusion


Company: Pfizer Ltd
BNF category: Infections
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 29/09/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, ceftazidime/avibactam (Zavicefta®) cannot be endorsed for use within NHS Wales for the treatment of the following infections in adults: complicated intra-abdominal Infection; complicated urinary tract infection, including pyelonephritis; hospital-acquired pneumonia, including ventilator-associated pneumonia; infections due to aerobic Gram-negative organisms in adult patients with limited treatment options.
Statement of Advice (SOA)
Download